Zobrazeno 1 - 10
of 973
pro vyhledávání: '"autoimmune rheumatic diseases"'
Autor:
Yukai Wang, Shaoqi Chen, Shaoyu Zheng, Zexuan Zhou, Weijin Zhang, Guangzhou Du, Angelina Mikish, Barbara Ruaro, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Luna Gargani, Marco Matucci-Cerinic, Daniel E Furst
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Systemic autoimmune rheumatic diseases (SARDs) related pulmonary disease is highly prevalent, with variable clinical presentation and behavior, and thus is associated with poor outcomes and negatively impacts quality of life. Chest high reso
Externí odkaz:
https://doaj.org/article/df30442c4ebe4e88999340266017ada4
Autor:
Tjaša Šinkovec Savšek, Mojca Zajc Avramovič, Tadej Avčin, Miša Korva, Tatjana Avšič-Županc, Nataša Toplak
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Paediatric patients with autoimmune rheumatic diseases (pARD) have a dysregulated immune system, so infections present a major threat to them. To prevent severe COVID-19 infections we aimed to vaccinate them as soon as possible. S
Externí odkaz:
https://doaj.org/article/173419f1e2e54a93a1f83719c69ef921
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Autoimmune rheumatic diseases (ARD) present a significant global health challenge characterized by a rising prevalence. These highly heterogeneous diseases involve complex pathophysiological mechanisms, leading to variable treatment efficacies across
Externí odkaz:
https://doaj.org/article/ce8b7201d5954035a472bfcb4e892f84
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 3, Pp 262-279 (2024)
Autoimmunity is a pathological process associated with a violation of immunological tolerance to normal structural components of the body (autoantigens), associated with the predominance of active (adaptive) immunity and manifested by hyperproduction
Externí odkaz:
https://doaj.org/article/7b81332e885b4385851242eb44dd3651
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 5, Pp 1904-1910 (2024)
Introduction: The Coronavirus disease 2019 (COVID-19) pandemic has been the biggest threat to humankind during the last 3 years. It has caused the loss of more than 6.9 million precious lives across the world. The only method by which the massacre co
Externí odkaz:
https://doaj.org/article/f5a878090cb748128719ede264df7c89
Publikováno v:
Journal of Laboratory Medicine, Vol 48, Iss 2, Pp 61-69 (2024)
Detection of specific antinuclear antibodies is very important in term of diagnosis, prognosis and management of patients with systemic autoimmune rheumatic diseases. Chemiluminescence microarray immunoassay (CLMIA) is a microdot array-based method t
Externí odkaz:
https://doaj.org/article/2cd8ed17d5f544f3909168d8288859f8
Autor:
Jinjiao Li, Bao Li
Publikováno v:
Heliyon, Vol 10, Iss 17, Pp e37045- (2024)
Background: Numerous studies have investigated a possible correlation between Epstein-Barr virus (EBV) and autoimmune rheumatic diseases (ARDs). However, establishing a cause-and-effect relationship remains a challenging endeavor. This study employs
Externí odkaz:
https://doaj.org/article/1d3927a742d940fb84d9a5ab2aa23854
Autor:
Annagrazia Cecere, Martina Perazzolo Marra, Elisabetta Zanatta, Giovanni Civieri, Sabino Iliceto, Francesco Tona
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Autoimmune rheumatic diseases (ARDs) are a heterogeneous group of disorders characterized by an inappropriate immune reactivity against different body tissues. Patients affected by ARDs present increased cardiovascular morbidity and mortality, which
Externí odkaz:
https://doaj.org/article/76de7e72daf941a1801c287b909429ac
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Autoimmune rheumatic diseases comprise a group of immune-related disorders characterized by non-organ-specific inflammation. These diseases include systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), ankylosing spondylitis (AS), gout, amon
Externí odkaz:
https://doaj.org/article/b6e44f9b8630404795edfdfc5a548a0f
Autor:
Maria Jose Gallardo-Nelson, Marcos Cruces, Yolanda M. Gómez, Constanza Fuenzalida, Javiera Silva, Laura Aravena-Traipi, Eduardo Nuñez, Aracelly Gaete-Angel, Elizabeth Rivas-Yañez, Alexis M. Kalergis, Ricardo Soto-Rifo, Fernando Valiente-Echeverria
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Objectiveto evaluate the immune response to the SARS-CoV-2 vaccines in adults with immune-mediated rheumatic diseases (IMRDs) in comparison to healthy individuals, observed 1-20 weeks following the fourth vaccine dose. Additionally, to evaluate the i
Externí odkaz:
https://doaj.org/article/797b472d2e7b4a3ebae22d096dbd9f00